SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

$RARI is an ERC-20 token that controls the RARI Foundation treasury and governs the Rarible protocol and RARI Chain. The token was issued in 2020 with a max. supply of 25 million $RARI.

Rarible

Rarible is currently trending due to community speculation around its ultra-low circulating supply and potential for high-percentage gains if volume increases. Traders are actively debating the token's long-term utility in the NFT sector while calling for broader exchange listings to catalyze a significant price move.

Algorand is a scalable, secure, and decentralized digital currency and smart contract platform. Its protocol uses a variation of Proof-of-Stake (PoS) called Pure PoS (PPoS) to secure the network and reach consensus on block production. Developers can build decentralized applications (dApps) using familiar programming languages, including Python, which Algorand supports natively. Its infrastructure enables various use cases, including payment systems, digital identity solutions, supply-chain tracking, and financial services. The protocol's architecture allows for tokenization of assets and the development of smart contracts, while its technical specifications support both retail users seeking basic transaction capabilities and enterprises requiring more, complex, blockchain solutions.

Algorand

Algorand is seeing significant community discussion driven by a major research paper highlighting its post-quantum cryptography features alongside broader market excitement about potential regulatory clarity and institutional adoption. Traders remain polarized, with many debating whether the current price action marks a genuine recovery or a temporary bounce within a long-term downtrend.

Welcome to the fabulous world of OKANE, where wealth meets wagging tails!   Inspired by the Japanese word for "money," OKANE is more than just a meme coin; it’s a celebration of all things cute, quirky, and oh-so-luxurious.  Meet our charming mascot, a pampered pup with a flair for the extravagant. With his sparkling collar and stylish shades, this adorable canine knows how to live the high life. Whether he’s lounging in a sun-soaked doggy mansion or attending exclusive puppy parties, our little tycoon embodies the spirit of prosperity and joy.

OKANE

OKANE is attracting attention for its controlled price action and steady accumulation patterns, with community members emphasizing a patient, long-term outlook on its market movement.

TOSHI

TOSHI is trending as investors debate whether the current price action represents a major accumulation opportunity or a bottoming-out phase. Community sentiment remains polarized, with some members expressing frustration over stagnant price action and market volatility, while others remain committed to long-term holding and aggressive buying of the dip.

Sharplink, Inc. is an institutional-grade Ethereum treasury platform that provides public market investors with exposure to ETH. The platform focuses on Ethereum, which is used in various stablecoin, tokenized real-world asset, and decentralized finance settlement applications. This allows for native yield generation and potential network growth opportunities with ETH. The company is also involved in the online affiliate marketing business. The company was founded in 2019 and is headquartered in Miami, FL.

Sharplink Inc.

SharpLink Gaming Ltd

SharpLink Gaming is garnering significant community attention as a high-upside Ethereum treasury play, with investors closely watching its massive crypto holdings and potential for a catch-up rally relative to net asset value. While the stock faces heavy downward pressure and skepticism regarding its management and dilution, the community remains divided between those calling it a long-term undervalued asset and others warning of a permanent downtrend.

Maul Coin

Maul Coin is generating buzz among traders who are actively coordinating raids to drive engagement and increase holder count, positioning it as a community-driven alternative to volatile projects. Community members are rallying behind the active involvement of the developer while focusing on building long-term growth and visibility across social platforms.

Bitcoin Cash is a hard fork of Bitcoin with a protocol upgrade to fix on-chain capacity. Bitcoin Cash intends to be a Bitcoin without Segregated Witness (SegWit) as soft fork, where upgrades of the protocol are done mainly through hard forks and without changing the original economic rules of the Bitcoin.  Bitcoin Cash (BCH) is released on 1st August 2017 as an upgraded version of the original Bitcoin Core software. The main upgrade is the increase in the block size limit from 1MB to 8MB. This effectively allows miners on the BCH chain to process up to 8 times more payments per second in comparison to Bitcoin. This makes for faster, cheaper transactions and a much smoother user experience.  Why was Bitcoin Cash Created?  The main objective of Bitcoin Cash is to to bring back the essential qualities of money inherent in the original Bitcoin software. Over the years, these qualities were filtered out of Bitcoin Core and progress was stifled by various people, organizations, and companies involved in Bitcoin protocol development. The result is that Bitcoin Core is currently unusable as money due to increasingly high fees per transactions and transfer times taking hours to complete. This is all because of the 1MB limitation of Bitcoin Core’s block size, causing it unable to accommodate to large number of transactions.  Essentially Bitcoin Cash is a community-activated upgrade (otherwise known as a hard fork) of Bitcoin that increased the block size to 8MB, solving the scaling issues that plague Bitcoin Core today.  Nov 16th 2018: A hashwar resulted in a split between Bitcoin SV and Bitcoin ABC

Bitcoin Cash

Bitcoin Cash is capturing community attention as investors debate its long-term viability, price potential, and its role as a peer-to-peer electronic cash alternative to Bitcoin. While some users express frustration over stagnant price action, others are focused on upcoming network upgrades and potential decoupling from broader crypto market volatility.

MediWound Ltd. is a biopharmaceutical company, which engages in the development, manufacture, and commercialization of products to address needs in the fields of severe burns, chronic wounds, and other hard-to-heal wounds. Its product NexoBrid, is an orphan biologic for eschar removal in severe burns. The company was founded by Lior Rosenberg and Marian Gorecki in January 2000 and is headquartered in Yavne, Israel.

MediWound Ltd

MediWound is currently trending as investors weigh the significant potential of its NexoBrid burn treatment and EscharEx chronic wound therapy against concerns regarding its long-term market performance and the volatility associated with its small-cap biotech status. Community sentiment remains deeply divided, with some highlighting the company's government-backed contracts and institutional support as catalysts for a potential buyout, while others aggressively short the stock, citing ongoing consolidation and the lack of a clear directional breakout.

EyePoint Plc is a biopharmaceutical company, which engages in the development and commercialization of therapeutics that treat eye disorders. It offers FDA-approved sustained-release treatments in ophthalmology under the DEXYCU, ILUVIEN, Verisome, Retisert, and Durasert brands. The company was founded in 1987 and is headquartered in Watertown, MA.

EyePoint Inc.

EyePoint Pharmaceuticals Inc

EyePoint Pharmaceuticals is seeing heavy volatility as investors debate the impact of the company's recent capital raise alongside optimism for its Phase 3 Duravyu trials in wet AMD and DME. Market participants are actively comparing EyePoints potential to competitor Ocular Therapeutix, with the community closely tracking institutional accumulation patterns and the timeline for upcoming pivotal clinical data.

Polygon

The community is debating the potential rebranding back to the original MATIC ticker to address persistent brand confusion, while many investors express frustration over price performance despite continued whale accumulation and institutional interest. Discussions remain polarized between those highlighting the network's growing utility in stablecoin payments and those deeply disappointed by the gap between development milestones and token price action.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

<ul class="summary-bullets"><li>Shkreli had earlier announced an investment in the company and expressed his desire to become the CEO.</li><li>Trading was twice halted within the first 15 minutes of the market opening.</li><li>QCLS said Martin Shkreli will add industry connections, early-stage growth expertise, and financial innovation insight as it scales its next-gen computing platform.</li></ul>Shares of Q/C Technologies, Inc. (QCLS) crashed over 13% in volatile trading on Tuesday, after the company appointed Martin Shkreli as a strategic advisor.Earlier in the session, <a href="https://stocktwits.com/symbol/QCLS">QCLS</a> had climbed more than 11%. However, trading was twice halted within the first 15 minutes of the market opening.<h2 class="st-heading-2">Shkreli Appointed Advisor</h2>The company said former hedge fund manager and pharmaceutical executive Martin Shkreli will bring industry connections, early-stage growth experience, and insights into financial innovation as it scales its next-generation computing platform.Shkreli joins an advisory roster that already includes noted technologist James Altucher, strengthening Q/C's expertise across computing, AI, and blockchain.“I'm convinced that the next leap in frontier computing is optical, not purely quantum. Q/C’s ‘quantum class’ technology approach bridges frameworks, offering the potential for extraordinary performance and efficiency gains,” Shkreli said.Q/C’s flagship QC-LPU100 laser processing units use light rather than electrical signals to deliver efficient, high-performance computing. In partnership with Lightsolver, the company is adapting its technology for real-world blockchain applications.In a post on X last week, Shkreli announced an investment in the company and expressed his desire to become the CEO. Shkreli also added that the near-term target for the stock was $100.<stembedurl>https://x.com/MartinShkreli/status/1996225504416792760</stembedurl>The stock surged 38% that day, followed by a 48% jump in the following session.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>Despite the intraday decline, retail sentiment on Stocktwits remained in the ‘extremely bullish’ territory, accompanied by ‘extremely high’ message volumes. QCLS was among the top trending tickers on Stocktwits.One user on the platform expects the stock to climb to $11. It is currently trading at $7.7.<stembedurl>https://stocktwits.com/PoplarAve/message/638553929</stembedurl>&nbsp;Also See: <a href="https://stocktwits.com/news-articles/markets/equity/what-is-purchasing-manager-s-index/cLIrUN7REZr">What Is Purchasing Manager’s Index?</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Artistic representation of a trending chart.

‘Pharma Bro’ Martin Shkreli Becomes Strategic Advisor To This Company – Stock Slumps 13% In Volatile Session

QCLS stock had surged 11% before declining 13% in the first half hour of trade on Wednesday.

Equity

<ul class="summary-bullets"><li>Shkreli said that he would join the company as CEO if President Trump allowed it.</li><li>QCLS was formerly known as TNF Pharmaceuticals and announced a name change in September 2025 as it pivoted to become a quantum-class computing company.</li></ul>Q/C Technologies Inc. (QCLS) shares soared over 60% on Thursday, extending Wednesday’s gains as American pharma investor Martin Shkreli announced that he had purchased the company’s shares.“We bought a photonic/optical computing stock: $QCLS. I'm convinced that the answer to frontier computing is optical, not quantum. we're calling it "quantum class" so investors understand it,” Shkreli said in a post on X. He also added that he would join the company as CEO if President Trump allowed it.Shkreli also noted that his near-term target on the stock is $100. Currently, QCLS shares are trading around $7.<figure class="image"><a class="st-link-external" href="https://x.com/MartinShkreli/status/1996225504416792760" target="_blank" rel="noopener noreferrer nofollow"><img style="aspect-ratio:1171/488;" src="https://news.stocktwits-cdn.com/Screenshot_2025_12_04_at_9_37_05_PM_png_4d4226b6e5.webp" alt="Shkreli said on X that he bought QCLS." width="1171" height="488"></a></figure><h2 class="st-heading-2"> Quantum Leaps</h2>Shkreli said that photonic technology delivers on the promise of quantum computing with realistic capabilities, while matrix multiplication could be far faster than GPUs.QCLS was formerly known as TNF Pharmaceuticals, Inc. (TNFA). The company announced a name change in September to represent its strategic pivot from pharmaceuticals to quantum-class computing.In October, the company obtained exclusive global digital rights to LightSolver’s laser processing unit (LPU) that can be used in the cryptocurrency verticals.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>On Stocktwits, retail sentiment for the stock was ‘extremely bullish’ while message volume jumped to ‘extremely high’ at the time of writing. The stock was also the second-most-trending ticker on the platform.<figure class="image"><img style="aspect-ratio:1281/156;" src="https://news.stocktwits-cdn.com/Screenshot_2025_12_04_at_10_04_48_PM_png_ecefdba5d2.webp" alt="On Stocktwits, retail sentiment was ‘extremely bullish’ while message volume jumped to ‘extremely high’." width="1281" height="156"></figure>One user highlighted their positive take on the stock.<stembedurl>https://stocktwits.com/BullishBee/message/638169244</stembedurl>Another user noted that the stock was ready for another rally.<stembedurl>https://stocktwits.com/RM7391/message/638168492</stembedurl>Shares of QCLS are down over 98% year-to-date.Also Read: <a href="https://stocktwits.com/news-articles/markets/equity/brr-stock-jumps-after-ceo-pompiliano-accepts-1-salary-with-stock-incentives/cLIiP4NREjB">BRR Stock Jumps After CEO Anthony Pompiliano Accepts $1 Salary With Stock Incentives</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.&nbsp;

Quantum Computing, Quantum Physics, Quantum mechanics, Science, Technology. (Representative image courtesy of Just_Super via Getty Images)

Why Did QCLS Stock Surge Over 60% Today?

QCLS shares rallied after American pharma investor Martin Shkreli said on X that he had bought the stock, giving it a near-term price target of $100. 

<ul class="summary-bullets"><li>The stake sale comes on the heels of the company increasing its stake in TNF Pharmaceuticals in September by an additional $3 million.&nbsp;</li><li>PharmaCyte said that it plans to continue pursuing value-accretive investment opportunities and disciplined operational management.&nbsp;</li><li>The company said that monetizing its stake in Femasys will help strengthen its financial position.</li></ul> PharmaCyte Biotech, Inc. (PMCB) said on Tuesday that it sold its stake in Femasys Inc. (FEMY), thereby increasing its cash and marketable securities to about $20 million.The company had cash and marketable securities of only about $13.3 million as of the end of July. The company <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://ir.pharmacyte.com/press-releases/detail/319/pharmacyte-biotech-successfully-monetizes-femasys-stake">said</a> that monetizing its stake in Femasys will help strengthen its financial position.Shares of <a href="https://stocktwits.com/symbol/PMCB">PMCB </a>traded 25% higher at the time of writing.<h2 class="st-heading-2">PharmaCyte’s Financial Position</h2>CEO Josh Silverman stated that the successful monetization of the Femasys position demonstrates the effectiveness of the strategic and disciplined capital allocation approach. “We are committed to deploying shareholder capital intelligently, balancing near-term returns with opportunities that can deliver sustained value creation,” he said.Overall, PharmaCyte now has approximately $25 million in marketable securities, in addition to roughly $20 million in cash. The company highlighted its low stock price below $1 and added that it plans to continue pursuing value-accretive investment opportunities and disciplined operational management.The stake sale comes on the heels of the company increasing its stake in Q/C Technologies, formerly known as TNF Pharmaceuticals, in September by an additional $3 million.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>On Stocktwits, retail sentiment around PMCB jumped from ‘bullish’ to ‘extremely bullish’ territory over the past 24 hours, while message volume rose from ‘high’ to ‘extremely high’ levels.A Stocktwits user opined that the news shows the company has ways to generate cash without doing share offerings.<stembedurl>https://stocktwits.com/MadBat/message/637404061</stembedurl>Another expects the stock to cross the $1 threshold.<stembedurl>https://stocktwits.com/cbt2020/message/637412358</stembedurl>PMCB stock fell 48% this year and by about 53% over the past 12 months.&nbsp;Also See: <a href="https://stocktwits.com/news-articles/markets/equity/nio-stock-slips-after-q4-revenue-guidance-disappoints/cL52NcEREgI">Nio Stock Slips After Q4 Revenue Guidance Disappoints</a>For updates and corrections, email newsroom[at]stocktwits[dot]com

Rising stock market chart on a trading board background.

PMCB Stock Jumps 25% After Company Sells Stake In Femasys

PharmaCyte noted that it now has approximately $25 million in marketable securities, in addition to roughly $20 million in cash.

Q/C Technologies, Inc. (QCLS) stock surged 15% in the premarket session and became the top trending ticker among equities on Stocktwits on Friday morning. The stock is on its way toward the $6 mark, last seen in August this year.The stock has garnered significant retail attention in recent days following the firm's announcement of a shift in focus to high-performance computing tailored for the cryptocurrency space. Momentum around quantum computing, triggered by recent&nbsp;advancements in both quantum hardware and software, along with efforts to build more powerful quantum machines, also helped build interest around the stock.Formerly known as&nbsp;TNF Pharmaceuticals Inc., the company changed its name to Q/C Technologies to reflect its focus towards quantum-class computing, catering to crypto and blockchain applications.Retail sentiment around&nbsp;<a href="https://stocktwits.com/symbol/QCLS">Q/C Technologies' stock</a>&nbsp;jumped to ‘extremely bullish’ from ‘neutral’ territory the previous day. Message volume improved to ‘extremely high’ from ‘low’ levels in 24 hours.&nbsp;On September 24, the company stated that it secured exclusive worldwide rights to a laser-based processor developed by LightSolver. This light-speed laser processing unit (LPU) boosts computing by leveraging the speed and efficiency of photons over traditional semiconductor methods.LightSolver’s LPU is said to reduce power usage by up to 90% while outperforming current graphics processing units (GPUs) and quantum computing platforms in both speed and reliability. In addition to performance improvements, the system provides enhanced security for blockchain networks, a feature of growing importance for decentralized finance and cryptocurrency protocols.Q/C Technologies’ stock has lost over 96% in the last 12 months.&nbsp;Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/howard-lutnick-pushes-back-on-nvidia-uae-ai-chip-deal-report-says/chCu4zUR3fi">Howard Lutnick Pushes Back On Nvidia’s Multi-Billion-Dollar UAE AI Chip Deal? Report Says Delay Leaves Jensen Huang Frustrated</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

A quantum computer being built by the start-up IQM Germany is located in a data center.

QCLS Stock Surges 15% In Pre-Market Today, Inches Closer To $6 Mark 

The stock has garnered significant retail attention in recent days following the firm's announcement of a shift in focus to high-performance computing tailored for the cryptocurrency space. 

Q/C Technologies, Inc. engages in the provision of energy-efficient blockchain and cryptocurrency infrastructure through quantum-class laser-based computing. The company was founded in 1989 and is headquartered in New York, NY.

Q/C Technologies Inc.

Opendoor ($OPEN)

Strategy ($MSTR)

American Eagle ($AEO)

Ondas Inc. ($ONDS)

The stock that proved the power of the crowd. Fueled by community energy and social momentum, this winner captivated retail investors regardless of what the "experts" or traditional fundamentals had to say.

QCLS
Q/C Technologies Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest QCLS News

QCLSQ/C Technologies Inc.